-
Entity
-
Individual
-
Location
-
C/O Kiniksa Pharmaceuticals, Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
-
Summary
-
The estimated net worth of Thomas W. Beetham is at least $1.26M dollars as of March 4, 2025. Thomas W. Beetham is the Chief Operating Officer of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $1.02M. Thomas W. Beetham is the Title: Chief Legal Officer and Secretary of Magenta Therapeutics, Inc. and owns shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock worth about $239K.